未登录

J

James M. Angelastro

university of california davis

H指数:29

被引数:2,823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dpep, a Cell-Penetrating Peptide Targeting ATF5, CEBPB and CEBPD, Synergistically Combines with ABT-263 and Decitabine to Inhibit Cancer Cell Growth and Overcome Dpep Resistance

Dpep，一种靶向ATF5、CEBPB和CEBPD的穿膜肽，与ABT-263和地西他滨协同抑制癌细胞生长并克服Dpep耐药性

IF5.2

2026-05-010

OAAI

“Cytochrome P450 2B6 Downregulation by Cell-Penetrating Dominant-Negative ATF5 Peptide in Glioblastoma Cells.”

“细胞穿透性显性阴性ATF5肽对胶质母细胞瘤细胞中Cytochrome P450 2B6的下调作用。”

Drug Metabolism and Disposition

IF4

2025-10-080

OAAI

Antagonizing beta-2 adrenergic receptor's function triggers death in glioma cells and down- regulates survivin

CANCER RESEARCH

IF16.6

2024-03-220

PRE

A complex of Wnt/planar cell polarity signaling components Vangl1 and Fzd7 drives glioblastoma multiforme malignant properties

Wnt/平面细胞极性信号成分Vangl1和Fzd7的复合物驱动多形性胶质母细胞瘤的恶性特性

IF10.1

2023-07-013

OAAI

Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers

IF5.2

2023-02-1114

OAAI

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2021-01-0125

OAAI

Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells

PHARMACEUTICALS

IF4.8

2020-11-247

OAAI

PRMT1 promotes neuroblastoma cell survival through ATF5

IF6.4

2020-05-1529

OAAI

Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD

MOLECULAR CANCER RESEARCH

IF4.7

2020-02-0330

OAAI

Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer

IF4.5

2020-01-019

PREAI

Dominant-negative ATF5 rapidly depletes survivin in tumor cells

CELL DEATH & DISEASE

IF9.6

2019-09-2415

OAAI

Targeting epigenetic dysregulation in isocitrate dehydrogenase mutant glioblastoma

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Targeting ATF5 in Cancer

TRENDS IN CANCER

IF17.5

2017-07-0126

OAAI

Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination

IF7.3

2017-05-0848

OAAI

A novel cell-penetrating peptide targeting ATF5 (CP-d/n-ATF5) exerts anti-cancer activity in vitro and in vivo against a broad spectrum of human cancers

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas

IF7.3

2011-07-0435

OAAI

Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development

HUMAN MOLECULAR GENETICS

IF3.2

2010-10-0869

OAAI

Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells

MOLECULAR CANCER RESEARCH

IF4.7

2010-08-1681

OAAI

Identification of a Novel DNA Binding Site and a Transcriptional Target for Activating Transcription Factor 5 in C6 Glioma and MCF-7 Breast Cancer Cells

MOLECULAR CANCER RESEARCH

IF4.7

2009-06-2345

OAAI

Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2007-05-2225

PREAI